Heart Failure- the new End Point

被引：0
|
作者：
Tschoepe, D. [1 ,2 ]
机构：
[1] UK RUB, Stiftung DHD, Georgstr 11, D-32545 Bad Oeynhausen, Germany
[2] UK RUB, Diabet Zentrum HDZ NRW, Georgstr 11, D-32545 Bad Oeynhausen, Germany
来源：
DIABETES STOFFWECHSEL UND HERZ | 2016年 / 25卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：132 / 132
页数：1
相关论文
共 50 条
  • [31] Tolvaptan in the very elderly with acute decompensated heart failure- a therapeutic option worth of consideration
    Ndrepepa, Gjin
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2017, 18 (03): : 213 - 214
  • [32] Drug discovery for heart failure: a new era or the end of the pipeline?
    David M. Kaye
    Henry Krum
    Nature Reviews Drug Discovery, 2007, 6 : 127 - 139
  • [33] Drug discovery for heart failure: a new era or the end of the pipeline?
    Kaye, David M.
    Krum, Henry
    NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (02) : 127 - 139
  • [34] A cross-sectoral study to individually optimize therapy in heart failure- "AMPEL" trial
    Brunelli, L.
    Schreier, G.
    Hayn, D.
    Kreiner, K.
    Lauschensky, A.
    Wiesmueler, F.
    Baumgartner, M.
    Pfeifer, B.
    Neururer, S.
    Bauer, A.
    Poelzl, G.
    WIENER KLINISCHE WOCHENSCHRIFT, 2023, 135 : S388 - S388
  • [35] Risk of heart failure- and cardiac death gradually increases with more right ventricular pacing
    Udo, Erik O.
    van Hemel, Norbert M.
    Zuithoff, Nicolaas P. A.
    Doevendans, Pieter A.
    Moons, Karel G. M.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 185 : 95 - 100
  • [36] Comparison of Outcome Adjudication by Investigators and by a Central End Point Committee in Heart Failure Trials Experience of the SHIFT Heart Failure Study
    Tyl, Benoit
    Lopez Sendon, Jose
    Borer, Jeffrey S.
    Lopez De Sa, Esteban
    Lerebours, Guy
    Varin, Claire
    De Montigny, Aurelie
    Pannaux, Matthieu
    Komajda, Michel
    CIRCULATION-HEART FAILURE, 2020, 13 (07) : 123 - 131
  • [37] Omecamtiv Mecarbil use in systolic heart failure- Results of the GALACTIC-HF trial
    Shah, Syed Raza
    Ali, Arroj
    Ikram, Sohail
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2021, 14 (04) : 407 - 409
  • [38] Is heart failure a debatable end-point for biphosphonate treatment in older osteoporotic population?
    Canpolat, U.
    Canpolat, A. Gokcay
    Aras, D.
    Aydogdu, S.
    JOURNAL OF INTERNAL MEDICINE, 2014, 275 (02) : 199 - 200
  • [39] Influenza Activity is Associated With Hospitalizations for Heart Failure- Results From the Atherosclerosis Risk in Communities Study
    Kytomaa, Sonja
    Hegde, Sheila
    Vardeny, Orly
    Claggett, Brian
    Udell, Jacob
    Solomon, Scott
    CIRCULATION, 2018, 138
  • [40] HYPERCALCEMIA OF IMMOBILIZATION IN RENAL FAILURE- A CASE REPORT
    Chandra, Kalyani
    Chin, Andrew
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2015, 65 (04) : A25 - A25
12345